生物製藥第三方物流市場規模、佔有率和趨勢分析報告:按供應鏈、按服務類型、按地區和細分趨勢:2023-2030
市場調查報告書
商品編碼
1321325

生物製藥第三方物流市場規模、佔有率和趨勢分析報告:按供應鏈、按服務類型、按地區和細分趨勢:2023-2030

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

生物製藥 3PL 市場成長和趨勢

Grand View Research, Inc.最新報告顯示,到2030年,全球生物製藥第三方物流(3PL)市場預計將達到1985億美元。

預計 2023 年至 2030 年該市場將以 6.0% 的年複合成長率擴張。對跨地區運輸生物製劑的溫控物流服務的需求不斷成長,以及生物製藥公司擴大分銷網路以增加銷售隊伍,正在推動市場成長,這是一個促進因素。新興國家擴大採用自動化存儲和搜尋系統是醫藥物流公司的持續趨勢,並且正在獲得巨大的吸引力。

此外,市場預計將受到從小分子藥物向生物製藥(主要是疫苗和生物製劑)轉型趨勢的推動。由於這些小分子藥物是溫度敏感產品,對溫控運輸和儲存的需求不斷增加,這是市場成長的一個因素。技術進步是推動市場成長的主要因素之一。移動雲解決方案、倉庫機器人和資料挖掘等技術已經改變了整個 3PL 領域。借助這些先進技術,3PL 公司能夠在運輸過程中保持產品所需的溫度。

這降低了產品複雜性和人為錯誤。大多數生物藥品對溫度非常敏感,必須在要求的溫度下儲存。此類產品需要追踪設備進行監控直至交付。例如,2023年5月,Tridentify推出了具有創新能力的即時冷鏈監控系統,能夠持續追踪冷鏈上運輸的產品的穩定性和剩餘保存期限。該系統將通過提供對藥物穩定性和剩餘保存期限的即時、詳細洞察,徹底改變公司監控營運和管理穩定性預算的方式。

此外,出於環境考慮和成本考慮,商業產品的運輸方式正逐漸從空運轉向海運,從道路運輸轉向多式聯運(鐵路和卡車)。這些製藥公司主要使用多式聯運來減少碳排放。持續的趨勢表明,製藥商正在轉向海運以降低成本和風險因素。對於冷鏈產品,企業還是更青睞航空運輸。然而,一些大型製藥公司計劃通過海運運輸其70%的產品,其中包括冷鏈產品。

生物製藥 3PL 市場報告亮點

  • 到2022年,由於無溫藥品的銷售量很大,非冷鏈物流領域將佔銷售額的最大佔有率,達到79.7%。
  • 在細胞療法、疫苗和檢測套組等生物製品需求的推動下,冷鏈物流領域預計在預測期內年複合成長率8.8%。
  • 倉儲業佔比最大,2022年為43.3%。由於企業內部能力不足,交通運輸行業在 2022 年也佔據了很大的收入佔有率。
  • 由於生物製藥進出口增加,2022 年北美地區收入佔比最大,超過 42%。
  • 由於高齡化以及藥品銷售從品牌製造商轉向非專利製造商的轉變,亞太地區預計在預測期內年複合成長率為 7.4%。
  • 主要企業正在採取多項戰略舉措來提高其在市場上的影響力。例如,2021年2月,德迅與中國最大的非國有藥品分銷商九州通建立合作夥伴關係,以加強其在中國的醫療保健和藥品物流業務。

目錄

第1章 調查方法和範圍

  • 市場區隔和範圍
  • 調查方法
  • 資訊或資料分析
  • 調查方法
  • 調查範圍和先決條件
  • 市場形成和檢驗
  • 國家/地區分部佔有率計算
  • 資料來源列表

第2章 執行摘要

第3章 生物製藥第三方物流市場變量、趨勢和範圍

  • 市場譜系預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 生物製藥第三方物流市場分析工具
    • 行業分析-波特
    • PESTEL分析

第4章 生物製藥第三方物流市場:服務類型估算及趨勢分析

  • 分段儀表板
  • 生物製藥第三方物流市場:服務變化分析,十億美元,2022 年和 2030 年
  • 交通設施
    • 2018-2030年交通運輸市場收入估算和預測
    • 空運貨物
    • 海運
    • 陸運
  • 倉儲及保管
    • 2018-2030 年倉儲市場收入估算和預測
  • 其他
    • 2018-2030 年其他市場收入估計和預測

第5章 生物製藥第三方物流市場:供應鏈估算與趨勢分析

  • 分段儀表板
  • 生物製藥第三方物流市場:供應鏈變化分析,十億美元,2022 年和 2030 年
  • 新鮮食品的)低溫運輸系統
    • 2018-2030年冷鏈市場收入估算及預測
  • 非冷鏈
    • 2018-2030年非冷鏈市場收入估算及預測

第6章 生物醫藥第三方物流市場:區域估算與趨勢分析

  • 生物製藥第三方物流市場:2022年和2030年區域變化分析
  • 北美
    • 2018-2030年北美醫藥第三方物流市場估計與預測
    • 法律規範
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲生物製藥第三方物流市場估計和預測
    • 法律規範
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018年至2030年亞太生物製藥第三方物流市場估計和預測
    • 法律規範
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 鯛魚
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲生物製藥第三方物流市場估計和預測
    • 法律規範
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 2018-2030年中東和非洲生物製藥第三方物流市場估計與預測
    • 法律規範
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 公司分類
  • 2022 年公司市場佔有率分析
  • 主要私營企業名單
  • 戰略規劃
  • 公司簡介/名單
    • DHL International GmbH
    • SF Express
    • United Parcel Service of America, Inc.
    • AmerisourceBergen Corp.
    • DB Schenker
    • Kuehne and Nagel
    • Kerry Logistics Network Ltd.
    • Agility
Product Code: GVR-2-68038-773-5

Biopharmaceutical 3PL Market Growth & Trends

The global biopharmaceutical third-party logistics (3PL) market size is expected to reach USD 198.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2023 to 2030. Increasing demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the market growth. The rising adoption of automated storage and retrieval systems in emerging countries is an ongoing trend among pharmaceutical logistics companies that has gained significant traction.

Furthermore, the trend of shifting from small-molecule drugs to biopharmaceuticals, mainly vaccines and biologics, is projected to drive the market. Since, these small molecule drugs are temperature-sensitive products, demand for temperature-controlled transportation and storage increases and thus, is responsible for the market growth. Technological advancements are among the main factors drivingmarket growth. Technologies, such as mobile cloud solutions, warehouse robotics, and data mining, have changed the overall 3PL space. With the help of these advanced technologies, 3PL companies can maintain the required temperatures for products during transportation.

This will help in reducing complexities in products and human errors. Most biopharmaceutical products are very temperature-sensitive and hence should be stored at the required temperatures. These products require a tracking device for monitoring until delivery. For instance, in May 2023, Tridentify launched a real-time cold chain monitoring system with an innovative feature for continuously tracking the stability and remaining shelf life of products transported in the cold chain. It offers a thorough view of the stability and remaining shelf-life of pharmaceutical products in real-time, which will revolutionize the way companies monitor their operations and manage their stability budgets.

In addition, environmental concerns and costs have caused a slight shift in the means of transport used for commercial products, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck) transport. Intermodal transport is majorly used by these pharmaceutical companies to reduce their carbon footprint. The ongoing trend shows that pharmaceutical manufacturers have shifted to sea freight to reduce the cost and risk factors. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Biopharmaceutical 3PL Market Report Highlights

  • In 2022, the non-cold chain logistics segment held the largest share of 79.7% in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
  • The cold chain logistics segment is expected to register a CAGR of 8.8% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
  • The warehousing and storage segment held the largest share of 43.3% in 2022. The transportation segment also held a significant revenue share in 2022 due to the lack of internal capabilities of companies
  • North America held the largest revenue share of over 42% in 2022 owing to the rise in imports and exports for biopharmaceutical in the country
  • Asia Pacific is expected to register the fastest CAGR of 7.4% over the forecast period owing to the adoption of medicines from the aging population and the shift of drug sales from brand manufacturers to generic
  • The key players are undertaking several strategic initiatives to strengthen their market presence. For instance, in February 2021, Kuehne+Nagel entered into a partnership with China's largest non-state-owned pharma distribution company, Jointown, to enhance its footprint in healthcare & pharmaceutical logistics in China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. Methodology
  • 1.5. Research Scope and Assumptions
  • 1.6. Market Formulation & Validation
    • 1.6.1. COUNTRY MARKET: CAGR CALCULATION
  • 1.7. Country Based Segment Share Calculation
  • 1.8. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional Insights
  • 2.4. Competitive Insights
  • 2.5. Biopharmaceutical Third Party Logistics Market Snapshot
  • 2.6. Biopharmaceutical Third Party Logistics Market Segment Snapshot
  • 2.7. Biopharmaceutical Third Party Logistics Market Competitive Landscape Snapshot

Chapter 3. Biopharmaceutical Third Party Logistics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Biopharmaceutical Third-party Logistics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Biopharmaceutical Third-party Logistics Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopharmaceutical Third-party Logistics Market: Service Movement Analysis, USD Billion, 2022 & 2030
  • 4.3. Transportation
    • 4.3.1. Transportation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.2. Air Freight
      • 4.3.2.1. Air Freight Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.3. Sea Freight
      • 4.3.3.1. Sea Freight Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.4. Overland Transportation
      • 4.3.4.1. Overland Transportation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Warehousing & Storage
    • 4.4.1. Warehousing & Storage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Others
    • 4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Biopharmaceutical Third Party Logistics Market: Supply Chain Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopharmaceutical Third Party Logistics Market: Supply Chain Movement Analysis, USD Billion, 2022 & 2030
  • 5.3. Cold Chain
    • 5.3.1. Cold Chain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Non-Cold Chain
    • 5.4.1. Non-Cold Chain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Biopharmaceutical Third Party Logistics Market: Regional Estimates & Trend Analysis

  • 6.1. Biopharmaceutical Third Party Logistics Market: Regional Movement Analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. Regulatory Framework
    • 6.2.3. U.S.
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. U.S. Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Canada
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Canada Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. Regulatory Framework
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. UK Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. Germany
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Germany Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. France
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. France Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Italy
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Italy Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Spain
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Spain Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Denmark
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Denmark Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.9. Sweden
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Sweden Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.10. Norway
      • 6.3.10.1. Key Country Dynamics
      • 6.3.10.2. Competitive Scenario
      • 6.3.10.3. Norway Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. Regulatory Framework
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Japan Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. China
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. China Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. India
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. India Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Australia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Thailand Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.8. South Korea
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. South Korea Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Regulatory Framework
    • 6.5.3. Brazil
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Brazil Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Mexico Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Argentina
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Argentina Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Regulatory Framework
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. South Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Saudi Arabia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. UAE
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. UAE Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Kuwait
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Kuwait Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Share Analysis, 2022
  • 7.3. List of Key Private Players
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. DHL International GmbH
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. SF Express
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. United Parcel Service of America, Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. AmerisourceBergen Corp.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. DB Schenker
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Kuehne and Nagel
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Kerry Logistics Network Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Agility
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 4. Global Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 5. Global Biopharmaceutical Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)
  • Table 6. North America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 7. North America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 8. North America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 9. U.S. Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 10. U.S. Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 11. Canada Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 12. Canada Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 13. Europe Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 14. Europe Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 15. Europe Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 16. Germany Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 17. Germany Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 18. UK Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 19. UK Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 20. France Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 21. France Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 22. Italy Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 23. Italy Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 24. Spain Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 25. Spain Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 26. Denmark Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 27. Denmark Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 28. Sweden Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 29. Sweden Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 30. Norway Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 31. Norway Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 32. Asia Pacific Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 33. Asia Pacific Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 34. Asia Pacific Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 35. China Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 36. China Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 37. Japan Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 38. Japan Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 39. India Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 40. India Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 41. South Korea Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 42. South Korea Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 43. Australia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 44. Australia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 45. ThailandBiopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 46. ThailandBiopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 47. Latin America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 48. Latin America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 49. Latin America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 50. Brazil Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 51. Brazil Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 52. Mexico Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 53. Mexico Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 54. Argentina Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 55. Argentina Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 56. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 57. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 58. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 59. South Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 60. South Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 61. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 62. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 63. UAE Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 64. UAE Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 65. Kuwait Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 66. Kuwait Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Primary Research Pattern
  • Fig. 2 Market Research Approaches
  • Fig. 3 Value Chain-Based Sizing & Forecasting
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Biopharmaceutical Third-party Logistics Market, Market Segmentation
  • Fig. 6 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 7 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 9 Penetration & Growth Prospect Mapping
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Biopharmaceutical Third-party Logistics Market for Cold chain, 2018 - 2030 (USD Billion)
  • Fig. 15 Global Biopharmaceutical Third-party Logistics Market for Non-cold chain, 2018 - 2030 (USD Billion)
  • Fig. 16 Global Biopharmaceutical Third-party Logistics Market for Transportation, 2018 - 2030 (USD Billion)
  • Fig. 17 Global Biopharmaceutical Third-party Logistics Market for Air freight, 2018 - 2030 (USD Billion)
  • Fig. 18 Global Biopharmaceutical Third-party Logistics Market for Sea freight, 2018 - 2030 (USD Billion)
  • Fig. 19 Global Biopharmaceutical Third-party Logistics Market for Overland transportation, 2018 - 2030 (USD Billion)
  • Fig. 20 Global Biopharmaceutical Third-party Logistics Market for Warehousing and storage, 2018 - 2030 (USD Billion)
  • Fig. 21 Global Biopharmaceutical Third-party Logistics Market for Others, 2018 - 2030 (USD Billion)
  • Fig. 22 Regional Outlook, 2021 & 2030
  • Fig. 23 North America Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 24 U.S. Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 25 Canada Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 26 Europe Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 27 Germany Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 28 UK Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 29 France Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 30 Italy Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 31 Spain Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 32 Denmark Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 33 Sweden Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Norway Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Asia Pacific Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 36 Japan Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 37 China Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 38 India Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 39 Australia Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 40 South Korea Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Thailand Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Latin America Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Brazil Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Mexico Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Argentina Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 46 Middle East and Africa Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 47 South Africa Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Saudi Arabia Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 49 UAE Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Kuwait Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)